NCT07154290 2026-02-12
A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Regeneron Pharmaceuticals
Phase 2 Not yet recruiting
Regeneron Pharmaceuticals
M.D. Anderson Cancer Center